U.S., Sept. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07162870) titled 'Idiopathic Pulmonary Fibrosis Cohort of TCM' on June 29.
Brief Summary: This study, based on past registration records, evaluates the clinical efficacy of traditional Chinese medicine in treating IPF in the real world, identifies advantageous populations and clinical targets, and provides references for precision traditional Chinese medicine treatment.
Study Start Date: Sept. 05
Study Type: OBSERVATIONAL
Condition:
Idiopathic Pulmonary Fibrosis (IPF)
Intervention:
DRUG: Traditional Chinese medicine (TCM)
Regulated use of Chinese medicine treatment protocols is included as an exposure factor. Exposure is defined as taking the...